|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 |
| (11) | Number of the document | 2591103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11736498.4 |
| Date of filing the European patent application | 2011-07-06 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/043099 |
| Date | 2011-07-06 |
| (87) | Number | WO 2012/006372 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 361780 P | 2010-07-06 | US |
| (72) |
GEALL, Andrew, US
RAMSAUER, Katrin, US
OTTEN, Gillis, US
MANDL, Christian, US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | DELIVERY OF RNA TO DIFFERENT CELL TYPES |
| DELIVERY OF RNA TO DIFFERENT CELL TYPES |